Abstract WP113: Impact of Apixaban on Clinical Outcome of the Patients With Large Vessel Occlusion or Stenosis (alvo) Study

Shinichi Yoshimura,Nobuyuki Sakai,Hiroshi Yamagami,Masunari Shibata,Yukiko Enomoto,Norihito Fukawa,Yasushi Matsumoto,Masataka Takeuchi,Tadashi Nonaka,Fuminori Shimizu,Masayuki Ezura,Takahiro Ota,Taketo Hatano,Hajime Ota,Masafumi Morimoto,Takeshi Morimoto

Abstract WP113: Impact of Apixaban on Clinical Outcome of the Patients With Large Vessel Occlusion or Stenosis (alvo) Study

2020

Shinichi Yoshimura
Nobuyuki Sakai
Hiroshi Yamagami
Masunari Shibata
Yukiko Enomoto
Norihito Fukawa
Yasushi Matsumoto
Masataka Takeuchi
Tadashi Nonaka
Fuminori Shimizu
Masayuki Ezura
Takahiro Ota
Taketo Hatano
Hajime Ota
Masafumi Morimoto
Takeshi Morimoto

Background: Efficacy and safety of direct oral factor Xa inhibitor in patients with acute large vessel occlusion (LVO) and nonvalvular atrial fibrillation (NVAF) were questionable because recombina...

Keywords:

Factor Xa Inhibitor
Atrial fibrillation
Internal medicine
Medicine
Cardiology
Apixaban
Stroke
large vessel occlusion
in patient
Stenosis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations